reSee.it Video Transcript AI Summary
The pharmaceutical industry may face major concerns because it has become an alternative to palliative chemotherapy, radiotherapy, and surgery in large clinical studies on cancer, with trial sizes ranging into the thousands and cancer cases in the high hundreds through photodynamic therapy. A randomized control trial published in *The Lancet Oncology* involved 413 people, with a “red light” group performing almost 400% better than the non-red light group. In that trial, only 6% of the red light group received surgery, while 3% of the non-red light group received surgery, described as a 100% difference.
The transcript also highlights major post-surgical outcomes: after these surgeries, nine out of ten people will become impotent. Because of this, people are pursuing less invasive, more selective therapies that target tumor cells instead of “carpet bombing” the body or removing organs they want.
The transcript describes a concern that organ removal is happening because people do not think there is a better option. It frames this as a “forced” or “transgender” surgery dynamic occurring when better alternatives are not available, and identifies this lack of options as the biggest threat.